The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 23.00
Ask: 25.00
Change: 1.30 (5.73%)
Spread: 2.00 (8.696%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 22.70
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jan 2022 07:00

RNS Number : 8685Y
Mission Group PLC (The)
19 January 2022
 

19 January 2022

THE MISSION GROUP plc

 

("MISSION", "the Group") 

 

TRADING UPDATE AND NOTICE OF RESULTS

The MISSION Group plc (AIM: TMG), creator of Work That Counts comprising a network of 16 Agencies delivering real, sustainable growth for its Clients, today issues a trading update for the year ended 31 December 2021.

Trading update

 

MISSION continued to deliver an impressive and strong sequential trading recovery throughout the second half of the financial year. As a direct consequence, the Group was pleased to achieve an outstanding increase in profit levels against both H1 2021 and FY2020 and so expects a healthy full year headline PBT performance that is in line with market expectations.

 

Whilst trading conditions throughout 2021 remained challenging, due to the impact and disruption caused by the evolving pandemic on the Group's markets, the resilience of MISSION'S business model has underpinned its continued ability to deliver against this backdrop.

Further strategic progress has been made over the course of the year to expand MISSION'S Agency portfolio with the acquisition of Soul, a full-service customer engagement Agency that works with psychologists to help businesses better understand human nature and human behaviour, enhancing MISSION's creative and customer experience capability.

The Group has also benefitted from a full year of the now fully embedded behavioural science practice, Innovation Bubble, acquired in 2020. MISSION expects to continue to grow its roster of Agencies in 2022, alongside investing in building additional and enhanced capability to further support its Clients.

The development of its people also continues to be of key strategic importance to the Group and in 2022 MISSION will invest at record levels in recruiting and retaining the best talent. Whilst the Group recognises this will have some short-term impact on its cost base, it will ultimately underpin its ability to deliver in future years.

Strong cash management remains a key priority for the Group and, even after settling its last significant earn-out obligation, its year end net bank debt was £10.2m, in line with market expectations and giving MISSION significant headroom against its current debt facility. The highly cash generative nature of the Group means it is well placed to capitalise on the opportunities that 2022 will undoubtedly bring.

Whilst uncertainties remain about Covid-19 and its impact on the economy over the current year, the Board is confident that the Group is well positioned for sustainable growth and expects to achieve double-digit year on year PBT growth in 2022.

 

Notice of results

 

The Group expects to announce its final results on 29 March 2022.

James Clifton, Chief Executive of The MISSION Group plc, commented: "I am pleased that MISSION's strong trading momentum has continued, demonstrating our continued ability to deliver growth against an ever changing and challenging backdrop.

"Over the course of the year we have further strengthened the Group and our market proposition, meaning we are increasingly well positioned to continue to progress against our strategic priorities in 2022 and beyond. The coming year will see us place a significant focus on our biggest and most important asset - our people - as we look to recruit and retain the best talent to provide the best service to our Clients."

 

ENQUIRIES:

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

 

020 7462 1415

 

 

Mark Percy / James Thomas / Fiona Conroy

Shore Capital (Nomad and Broker)

020 7408 4090

 

 

 

Kate Hoare / Laura Stewart

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

NOTES TO EDITORS

 

MISSION is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit. Employing 1,000 people across 27 locations and 3 continents, the Group successfully combines its diverse expertise to produce Work That Counts for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands. www.themission.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWRBRUNUAAAR
Date   Source Headline
13th May 20247:00 amRNSResponse to Press Speculation & Possible Offer
13th May 20247:00 amRNSPossible All Share Offer for The Mission Group plc
2nd May 20244:12 pmRNSHolding(s) in Company
18th Apr 202410:00 amRNSIssue of Contingent Consideration Shares & TVR
2nd Apr 20247:00 amRNSFinal Results
28th Mar 20245:30 pmRNSFinal Results
17th Jan 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDISPOSAL UPDATE - PATHFINDR
20th Dec 20237:34 amRNSTrading Statement
24th Nov 202312:46 pmRNSBoard Change
7th Nov 20232:47 pmRNSNotification of Major Holdings
31st Oct 20235:07 pmRNSHolding(s) in Company
31st Oct 20239:29 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSTRADING UPDATE AND REVISED OUTLOOK FOR 2023
19th Oct 20236:25 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2023
25th Sep 202310:27 amRNSNEW CONTRACT WIN
20th Sep 20239:44 amRNSInvestor Presentation
27th Jul 20237:01 amRNSTrading Update
27th Jul 20237:00 amRNSChange of Adviser
20th Jun 20232:44 pmRNSResult of AGM
20th Jun 20237:00 amRNSDirector Dealing
3rd Apr 20237:00 amRNSDividend Declaration
28th Mar 20237:00 amRNSFinal Results
24th Mar 20237:00 amRNSInvestor Presentation
16th Mar 202310:16 amRNSLaunch Of New Integrated Growth Media Agency
14th Feb 20237:00 amRNSACQUISITION OF MEZZO LABS
12th Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSACQUISITION OF INFLUENCE SPORTS & MEDIA
31st Oct 20224:39 pmRNSHolding(s) in Company
27th Sep 20227:01 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2022
27th Sep 20227:00 amRNSCHANGES TO THE BOARD
26th Aug 202210:27 amRNSHolding(s) in Company
18th Aug 202210:30 amRNSEBT Share Dealing
17th Aug 20228:45 amRNSEBT Share Dealing
15th Aug 20222:29 pmRNSEBT Share Dealing
12th Aug 20227:00 amRNSEBT Share Dealing
10th Aug 20229:00 amRNSEBT Share Dealing
8th Aug 20228:51 amRNSEBT Share Dealing
5th Aug 20229:36 amRNSEBT Share Dealing
3rd Aug 20227:00 amRNSEBT Share Dealing
25th Jul 20223:47 pmRNSEBT Share Dealing
20th Jul 20228:22 amRNSEBT Share Dealing
19th Jul 20227:00 amRNSEBT Share Purchase
15th Jul 202210:22 amRNSEBT Share Purchase
14th Jul 20229:34 amRNSEBT Share Dealing
13th Jul 20227:00 amRNSTrading Update
8th Jul 20229:02 amRNSEBT Share Dealing
5th Jul 20223:44 pmRNSEBT Share Dealing
30th Jun 20228:55 amRNSEBT Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.